| Nov 4 |
Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates
|
| Nov 4 |
Krystal Biotech GAAP EPS of $0.91 beats by $0.01, revenue of $83.84M beats by $0.73M
|
| Nov 4 |
Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates
|
| Nov 1 |
Are Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock?
|
| Oct 29 |
Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
|
| Oct 28 |
Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth
|
| Oct 28 |
Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024
|
| Oct 18 |
All You Need to Know About Krystal Biotech (KRYS) Rating Upgrade to Buy
|
| Oct 16 |
State Street Corp's Strategic Acquisition in Krystal Biotech Inc
|
| Oct 14 |
Krystal Biotech: Q4 Catalysts Expected With VYJUVEK Revenue Growth Pressing On
|
